COVID-19 Diagnostics Market set to record exponential growth by 2030

Wilmington, Delaware, United States, Transparency Market Research Inc. - COVID-19, first detected in China in late 2019 and has since been declared a pandemic, is posing both a serious threat to vulnerable populations and a challenge to the global economy.

COVID-19 has the potential to take lives, overwhelm health systems, deplete the value of assets, and trigger lasting geopolitical change, as confirmed cases of COVID-19 increase and spread

Access Full Report @ 

Key Drivers and Restraints of Global COVID-19 Diagnostics market

COVID-19, caused by a coronavirus, has been spreading rampantly across the globe. People infected with coronavirus experience symptoms of mild to moderate respiratory illnesses. The disease is known to spread through the respiratory droplets of an infected person. Use of face masks was advocated for infected persons to curb the spread of the disease. As of November, 2020, the disease has spread to over 218 countries, globally, infecting over 60 million people.

Growing scare of infection among people and the asymptomatic spread of the disease have created a strong demand for COVID-19 diagnostics. Furthermore, ongoing efforts to flatten the curve of infection, globally, have prompted contact tracing and rapid diagnostic tests, which is likely to minimize the spread of the infection.

Growing pandemic of COVID-19 and rising fear among people, along with healthcare care professionals advocating early diagnostics to reduce the risk of infection, fuel the COVID-19 diagnostics market

Request Brochure of Report @ 

RT-PCR Test to Lead Global Market

The global COVID-19 diagnostics market can be segmented based on test type, end-user, and region

In terms of test type, the global COVID-19 diagnostics market can be divided into polymerase chain reaction (PCR), POC test, and immunoassay test. PCR tests are utilized to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies. Currently, there are two types of diagnostic tests– molecular tests, such as RT-PCR tests, that detect the virus’s genetic material, and antigen tests that detect specific proteins from the virus.

Based on end-user, the global COVID-19 diagnostics market can be classified into hospitals, physician's office & urgent care clinics, and diagnostic laboratories

Request For Custom Research @ 

North America to Lead the Global COVID-19 Diagnostics Market

The global COVID-19 diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Robust expansion of the market in the U.S. can be attributed to a significant rise in the number of people being affected with the novel coronavirus. Additionally, growing focus of market players on enhancing their production facilities to cater to a rise in the demand for COVID-19 diagnostics further boosts the global market.

Make an Enquiry before Buying @ 

Key Players Operating in Global COVID-19 Diagnostics market

Leading players in the global COVID-19 diagnostics market include:

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Perkin Elmer, Inc.

Global COVID-19 Diagnostics Market: Research Scope

Global COVID-19 Diagnostics Market, by Test Type

  • Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
  • POC Test
  • Immunoassay Test

Global COVID-19 Diagnostics Market, by End-user

  • Hospitals
  • Physician's Office & Urgent Care Clinics
  • Diagnostic Laboratories

More Related Reports by Transparency Market Research – 

Bone Graft Substitutes Market: Bone graft substitutes market is expected to attain a market value of US$ 3.9 Bn by the end of 2030

Linear Accelerators [LINAC] Market: Linear accelerators (LINAC) market is projected to cross US$ 4.1 Bn by the end of 2030

Cyclotron Market: The global cyclotron market was worth US$ 215.5 Mn and is projected to reach a value of US$ 304 Mn by the end of 2030

Heel Incision Devices Market: Heel incision devices market to cross valuation of US$ 231 Mn by 2030

Needle Biopsy Market: Needle biopsy market to cross valuation of US$ 1.2 Bn by 2030

Dental Practice Management Software Market: The global dental practice management software market was valued at US$ 1,984.4 Mn in 2018 and is anticipated to expand at a CAGR of 11.4% from 2019 to 2027

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market: Ornithine transcarbamylase (OTC) deficiency treatment market is projected to reach ~US$ 900 Mn by 2030

Hospital Asset Management Market: The global hospital asset management market was valued at US$ 5,986.5 Mn in 2018 and is anticipated to expand at a CAGR of 9.5% from 2019 to 2027

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453


Back to news